tiprankstipranks
Advertisement
Advertisement

CleanSpace Secures $891,000 R&D Rebate to Drive Respiratory Tech Innovation

Story Highlights
  • CleanSpace continues to advance high-end respiratory protection technology for industrial and healthcare users.
  • The company received an $891,000 R&D tax rebate to fund further product development and reinforce innovation leadership.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CleanSpace Secures $891,000 R&D Rebate to Drive Respiratory Tech Innovation

Claim 30% Off TipRanks

CleanSpace Holdings Ltd. ( (AU:CSX) ) just unveiled an announcement.

CleanSpace Holdings Limited, an Australian manufacturer of premium respiratory protection solutions for industrial and healthcare markets, continues to invest in advanced powered air purifying respirator technology developed by a team of biomedical engineers. Its focus on differentiated design and approved products aims to enhance worker safety and health outcomes across demanding end markets.

The company has received an $891,000 cash rebate under the Australian federal government’s R&D Tax Incentive program for the financial year ended 30 June 2025, with funds earmarked for ongoing product research and development. The rebate reinforces CleanSpace’s position as an innovation-led player in the PAPR segment, supporting continued product advancement and potentially strengthening its competitive edge and value proposition for industrial customers and frontline workers.

The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.56 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.

More about CleanSpace Holdings Ltd.

CleanSpace Holdings Limited is a Sydney-based designer and manufacturer of premium respiratory protection equipment, focusing on powered air purifying respirators for industrial and healthcare markets. Founded by biomedical engineers with experience in respiratory medical devices, the company targets improved health and safety outcomes through technologically advanced, differentiated products that offer higher protection for frontline workers.

Average Trading Volume: 26,347

Technical Sentiment Signal: Sell

Current Market Cap: A$47.42M

For an in-depth examination of CSX stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1